What is Lucid Diagnostics's cash ratio?

Lucid Diagnostics (LUCD) reported cash ratio of 0.9× in Q1 2026.

How has Lucid Diagnostics's cash ratio changed year-over-year?

Lucid Diagnostics's cash ratio increased by 37.7% year-over-year, from 0.7× to 0.9×.

What is the long-term trend for Lucid Diagnostics's cash ratio?

Over 4 years (2021 to 2025), Lucid Diagnostics's cash ratio has grown at a -44.3% compound annual growth rate (CAGR), from 12.6× to 1.2×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Lucid Diagnostics LUCD Cash ratio

Cash ratio at other companies

Castle BiosciencesCSTL

1.3×-1.1×

Guardant HealthGH

3.8×+0.2×

Biodesix, Inc.BDSX

1.8×+0.4×

Insight Molecular Diagnostics Inc. Common StockIMDX

2.3×-0.9×

Fulgent Genetics, Inc.FLGT

0.3×-0.8×

Personalis, Inc.PSNL

1.9×-0.5×

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's cash ratio?: Lucid Diagnostics (LUCD) reported cash ratio of 0.9× in Q1 2026.
How has Lucid Diagnostics's cash ratio changed year-over-year?: Lucid Diagnostics's cash ratio increased by 37.7% year-over-year, from 0.7× to 0.9×.
What is the long-term trend for Lucid Diagnostics's cash ratio?: Over 4 years (2021 to 2025), Lucid Diagnostics's cash ratio has grown at a -44.3% compound annual growth rate (CAGR), from 12.6× to 1.2×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.